Qianjiang Yongan Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 515.28 million compared to CNY 818.4 million a year ago. Revenue was CNY 578.44 million compared to CNY 826.91 million a year ago.

Net income was CNY 56.13 million compared to CNY 116.59 million a year ago. Basic earnings per share from continuing operations was CNY 0.1905 compared to CNY 0.3957 a year ago. Diluted earnings per share from continuing operations was CNY 0.1905.